Heparins

Heparins is an academic concept encompassing the study of a class of highly sulfated linear glycosaminoglycans primarily investigated for their potent anticoagulant properties. This research area examines their complex molecular structures, biosynthesis, interactions with coagulation factors and proteins, mechanisms of action in preventing blood clot formation, and their diverse therapeutic applications and development as antithrombotic agents.

5.4K

Publications

271.1K

Citations

16.9K

Authors

2.8K

Institutions

Publications per year

2017–2026

263

Authors

16.9K

Leading researchers in Heparins. Counts cover only their work on this concept, not their overall record.

PublicationsCitationsH-Index
TE

McMaster University

50

6.1K

34

AG

Universitätsmedizin Greifswald

35

4K

28

JH

McMaster University

35

5.8K

27

MP

Sanofi (France)

31

2.6K

26

UL

Uppsala University

29

3.9K

25

Rows per page

1–5 of 16.9K

Institutions

2.8K

Leading universities and research organizations in Heparins. Counts cover only their work on this concept, not their overall record.

PublicationsCitationsH-Index
McMaster University

Hamilton, Canada

425

30.9K

54

Harvard University

Cambridge, United States

364

38.2K

48

143

13.8K

34

University of Toronto

Toronto, Canada

138

8K

31

University of Michigan

Ann Arbor, United States

195

8.9K

28

Rows per page

1–5 of 2.8K

Venues

Leading journals and conferences in Heparins. Counts cover only their publications on this concept, not their overall record.

PublicationsCitationsH-Index

316

18.4K

72

442

18.8K

67

580

19.1K

60

91

11.1K

59

116

15K

54

Rows per page

1–5